Our Portfolio

First Bight will focus primarily on U.S. early-stage synthetic biology companies. We look for exceptional founders and technologies that are able to transform how we make things through biology. These companies will help the world to address the biggest challenges facing our world: health, supply chain, energy transition, employment, inflation, climate change and the environment.

First Bight targets investments of $1-2M per company and will seek board positions. We will leverage BioWell and our network to bring strategic partners to support and accelerate the technologies into commercially viable products.